MDT vs. SNY: A Head-to-Head Stock Comparison
Updated onHere’s a clear look at MDT and SNY, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.
Company Profile
MDT is a standard domestic listing, while SNY trades as an American Depositary Receipt (ADR), offering U.S. investors access to its foreign-listed shares.
| Symbol | MDT | SNY |
|---|---|---|
| Company Name | Medtronic plc | Sanofi |
| Country | Ireland | France |
| GICS Sector | Health Care | Health Care |
| GICS Industry | Health Care Equipment & Supplies | Pharmaceuticals |
| Market Capitalization | 124.32 billion USD | 127.74 billion USD |
| Exchange | NYSE | NasdaqGS |
| Listing Date | May 2, 1973 | July 1, 2002 |
| Security Type | Common Stock | ADR |
Historical Performance
This chart compares the performance of MDT and SNY by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.
Historical Performance at a Glance
| Symbol | MDT | SNY |
|---|---|---|
| 5-Day Price Return | 3.46% | 0.94% |
| 13-Week Price Return | 3.06% | 3.93% |
| 26-Week Price Return | 12.64% | -3.88% |
| 52-Week Price Return | 8.98% | -1.08% |
| Month-to-Date Return | 5.70% | 2.61% |
| Year-to-Date Return | 20.02% | -4.11% |
| 10-Day Avg. Volume | 6.26M | 1.47M |
| 3-Month Avg. Volume | 6.91M | 1.85M |
| 3-Month Volatility | 18.85% | 28.76% |
| Beta | 0.72 | 1.08 |
Profitability
Return on Equity (TTM)
MDT
9.62%
Health Care Equipment & Supplies Industry
- Max
- 29.82%
- Q3
- 15.54%
- Median
- 9.69%
- Q1
- 5.19%
- Min
- -7.98%
MDT’s Return on Equity of 9.62% is on par with the norm for the Health Care Equipment & Supplies industry, indicating its profitability relative to shareholder equity is typical for the sector.
SNY
18.76%
Pharmaceuticals Industry
- Max
- 38.95%
- Q3
- 20.34%
- Median
- 11.59%
- Q1
- 3.32%
- Min
- -10.91%
SNY’s Return on Equity of 18.76% is on par with the norm for the Pharmaceuticals industry, indicating its profitability relative to shareholder equity is typical for the sector.
Net Profit Margin (TTM)
MDT
13.63%
Health Care Equipment & Supplies Industry
- Max
- 24.65%
- Q3
- 14.10%
- Median
- 10.09%
- Q1
- 5.84%
- Min
- -6.13%
MDT’s Net Profit Margin of 13.63% is aligned with the median group of its peers in the Health Care Equipment & Supplies industry. This indicates its ability to convert revenue into profit is typical for the sector.
SNY
20.66%
Pharmaceuticals Industry
- Max
- 39.07%
- Q3
- 19.28%
- Median
- 13.48%
- Q1
- 5.73%
- Min
- -8.86%
A Net Profit Margin of 20.66% places SNY in the upper quartile for the Pharmaceuticals industry, signifying strong profitability and more effective cost management than most of its peers.
Operating Profit Margin (TTM)
MDT
17.90%
Health Care Equipment & Supplies Industry
- Max
- 31.34%
- Q3
- 18.36%
- Median
- 15.07%
- Q1
- 9.62%
- Min
- -0.13%
MDT’s Operating Profit Margin of 17.90% is around the midpoint for the Health Care Equipment & Supplies industry, indicating that its efficiency in managing core business operations is typical for the sector.
SNY
20.74%
Pharmaceuticals Industry
- Max
- 45.58%
- Q3
- 24.35%
- Median
- 18.05%
- Q1
- 7.58%
- Min
- -11.88%
SNY’s Operating Profit Margin of 20.74% is around the midpoint for the Pharmaceuticals industry, indicating that its efficiency in managing core business operations is typical for the sector.
Profitability at a Glance
| Symbol | MDT | SNY |
|---|---|---|
| Return on Equity (TTM) | 9.62% | 18.76% |
| Return on Assets (TTM) | 5.14% | 10.65% |
| Net Profit Margin (TTM) | 13.63% | 20.66% |
| Operating Profit Margin (TTM) | 17.90% | 20.74% |
| Gross Profit Margin (TTM) | 65.38% | 72.29% |
Financial Strength
Current Ratio (MRQ)
MDT
2.01
Health Care Equipment & Supplies Industry
- Max
- 4.97
- Q3
- 2.92
- Median
- 2.12
- Q1
- 1.54
- Min
- 0.86
MDT’s Current Ratio of 2.01 aligns with the median group of the Health Care Equipment & Supplies industry, indicating that its short-term liquidity is in line with its sector peers.
SNY
1.06
Pharmaceuticals Industry
- Max
- 5.45
- Q3
- 2.99
- Median
- 1.98
- Q1
- 1.29
- Min
- 0.78
SNY’s Current Ratio of 1.06 falls into the lower quartile for the Pharmaceuticals industry. This indicates a tighter liquidity situation and a more constrained capacity to handle short-term debt than many of its competitors.
Debt-to-Equity Ratio (MRQ)
MDT
0.60
Health Care Equipment & Supplies Industry
- Max
- 1.62
- Q3
- 0.74
- Median
- 0.47
- Q1
- 0.15
- Min
- 0.00
MDT’s Debt-to-Equity Ratio of 0.60 is typical for the Health Care Equipment & Supplies industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.
SNY
0.30
Pharmaceuticals Industry
- Max
- 1.79
- Q3
- 0.78
- Median
- 0.31
- Q1
- 0.08
- Min
- 0.00
SNY’s Debt-to-Equity Ratio of 0.30 is typical for the Pharmaceuticals industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.
Interest Coverage Ratio (TTM)
MDT
10.20
Health Care Equipment & Supplies Industry
- Max
- 56.35
- Q3
- 24.86
- Median
- 9.84
- Q1
- 3.86
- Min
- -21.65
MDT’s Interest Coverage Ratio of 10.20 is positioned comfortably within the norm for the Health Care Equipment & Supplies industry, indicating a standard and healthy capacity to cover its interest payments.
SNY
22.06
Pharmaceuticals Industry
- Max
- 103.95
- Q3
- 43.60
- Median
- 10.15
- Q1
- 2.37
- Min
- -42.71
SNY’s Interest Coverage Ratio of 22.06 is positioned comfortably within the norm for the Pharmaceuticals industry, indicating a standard and healthy capacity to cover its interest payments.
Financial Strength at a Glance
| Symbol | MDT | SNY |
|---|---|---|
| Current Ratio (MRQ) | 2.01 | 1.06 |
| Quick Ratio (MRQ) | 1.50 | 0.30 |
| Debt-to-Equity Ratio (MRQ) | 0.60 | 0.30 |
| Interest Coverage Ratio (TTM) | 10.20 | 22.06 |
Growth
Revenue Growth
EPS Growth
Dividend
Dividend Yield (TTM)
MDT
2.93%
Health Care Equipment & Supplies Industry
- Max
- 4.36%
- Q3
- 1.87%
- Median
- 0.82%
- Q1
- 0.00%
- Min
- 0.00%
With a Dividend Yield of 2.93%, MDT offers a more attractive income stream than most of its peers in the Health Care Equipment & Supplies industry, signaling a strong commitment to shareholder returns.
SNY
4.40%
Pharmaceuticals Industry
- Max
- 6.72%
- Q3
- 3.48%
- Median
- 1.90%
- Q1
- 0.00%
- Min
- 0.00%
With a Dividend Yield of 4.40%, SNY offers a more attractive income stream than most of its peers in the Pharmaceuticals industry, signaling a strong commitment to shareholder returns.
Dividend Payout Ratio (TTM)
MDT
77.27%
Health Care Equipment & Supplies Industry
- Max
- 160.00%
- Q3
- 67.77%
- Median
- 28.21%
- Q1
- 0.00%
- Min
- 0.00%
MDT’s Dividend Payout Ratio of 77.27% is in the upper quartile for the Health Care Equipment & Supplies industry. This indicates a strong commitment to shareholder returns but also suggests that a smaller portion of earnings is retained for reinvestment compared to many peers.
SNY
52.56%
Pharmaceuticals Industry
- Max
- 199.58%
- Q3
- 85.87%
- Median
- 49.36%
- Q1
- 1.12%
- Min
- 0.00%
SNY’s Dividend Payout Ratio of 52.56% is within the typical range for the Pharmaceuticals industry, suggesting a balanced approach between shareholder payouts and company reinvestment.
Dividend at a Glance
| Symbol | MDT | SNY |
|---|---|---|
| Dividend Yield (TTM) | 2.93% | 4.40% |
| Dividend Payout Ratio (TTM) | 77.27% | 52.56% |
Valuation
Price-to-Earnings Ratio (TTM)
MDT
26.39
Health Care Equipment & Supplies Industry
- Max
- 67.59
- Q3
- 41.41
- Median
- 33.11
- Q1
- 22.82
- Min
- 8.68
MDT’s P/E Ratio of 26.39 is within the middle range for the Health Care Equipment & Supplies industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.
SNY
7.90
Pharmaceuticals Industry
- Max
- 52.64
- Q3
- 29.89
- Median
- 20.77
- Q1
- 13.37
- Min
- 5.71
In the lower quartile for the Pharmaceuticals industry, SNY’s P/E Ratio of 7.90 suggests the stock may be undervalued compared to its peers, potentially presenting an attractive entry point for investors.
Price-to-Sales Ratio (TTM)
MDT
3.60
Health Care Equipment & Supplies Industry
- Max
- 9.49
- Q3
- 5.41
- Median
- 2.92
- Q1
- 1.97
- Min
- 0.61
MDT’s P/S Ratio of 3.60 aligns with the market consensus for the Health Care Equipment & Supplies industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.
SNY
1.63
Pharmaceuticals Industry
- Max
- 8.74
- Q3
- 4.66
- Median
- 2.37
- Q1
- 1.67
- Min
- 0.11
In the lower quartile for the Pharmaceuticals industry, SNY’s P/S Ratio of 1.63 indicates its revenue is valued more conservatively than most of its peers. This could present a compelling opportunity if the market has overlooked its sales-generating capabilities.
Price-to-Book Ratio (MRQ)
MDT
2.49
Health Care Equipment & Supplies Industry
- Max
- 10.77
- Q3
- 6.04
- Median
- 3.32
- Q1
- 2.31
- Min
- 0.83
MDT’s P/B Ratio of 2.49 is within the conventional range for the Health Care Equipment & Supplies industry. This shows a balanced market view, where the stock’s price is neither at a significant premium nor a discount to the book value of its peers.
SNY
1.32
Pharmaceuticals Industry
- Max
- 9.86
- Q3
- 5.28
- Median
- 2.48
- Q1
- 1.57
- Min
- 0.59
SNY’s P/B Ratio of 1.32 is in the lower quartile for the Pharmaceuticals industry. From a value investing perspective, this is favorable, as it suggests the stock is trading at a discount to its net asset value and may offer a greater margin of safety.
Valuation at a Glance
| Symbol | MDT | SNY |
|---|---|---|
| Price-to-Earnings Ratio (TTM) | 26.39 | 7.90 |
| Price-to-Sales Ratio (TTM) | 3.60 | 1.63 |
| Price-to-Book Ratio (MRQ) | 2.49 | 1.32 |
| Price-to-Free Cash Flow Ratio (TTM) | 23.19 | 10.85 |